95 related articles for article (PubMed ID: 28427799)
21. Prognostic Nutritional Index Predicts Toxicity in Head and Neck Cancer Patients Treated with Definitive Radiotherapy in Association with Chemotherapy.
Fanetti G; Polesel J; Fratta E; Muraro E; Lupato V; Alfieri S; Gobitti C; Minatel E; Matrone F; Caroli A; Revelant A; Lionello M; Zammattio Polentin V; Ferretti A; Guerrieri R; Chiovati P; Bertolin A; Giacomarra V; Paoli A; Vaccher E; Sartor G; Steffan A; Franchin G
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924581
[TBL] [Abstract][Full Text] [Related]
22. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
Kim R; Hahn S; Shin J; Ock CY; Kim M; Keam B; Kim TM; Kim DW; Heo DS
Cancer Res Treat; 2016 Jul; 48(3):907-16. PubMed ID: 26582394
[TBL] [Abstract][Full Text] [Related]
24. The effect of induction chemotherapy in patients with locally advanced nonsmall cell lung cancer who received chemoradiotherapy: A systematic review and meta-analysis.
Luo H; Yu X; Liang N; Xie J; Deng G; Liu Q; Zhang J; Zhang J; Ge H
Medicine (Baltimore); 2017 Feb; 96(8):e6165. PubMed ID: 28225501
[TBL] [Abstract][Full Text] [Related]
25. Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy x-ray absorptiometry.
Jackson W; Alexander N; Schipper M; Fig L; Feng F; Jolly S
Head Neck; 2014 Sep; 36(9):1356-62. PubMed ID: 23970480
[TBL] [Abstract][Full Text] [Related]
26. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].
Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984
[TBL] [Abstract][Full Text] [Related]
27. Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone.
Kitani Y; Kubota A; Furukawa M; Sato K; Nakayama Y; Nonaka T; Mizoguchi N
Eur Arch Otorhinolaryngol; 2016 May; 273(5):1293-8. PubMed ID: 25822291
[TBL] [Abstract][Full Text] [Related]
28. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
[TBL] [Abstract][Full Text] [Related]
29. Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Li WF; Chen L; Sun Y; Ma J
Chin J Cancer; 2016 Nov; 35(1):94. PubMed ID: 27846913
[TBL] [Abstract][Full Text] [Related]
30. Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy.
Chou WC; Chang PH; Chen PT; Wang HM; Yeh KY; Lu CH; Hung YS; Tung-Chieh Chang J; Tsang NM; Ho YW; Chen SY; Lee SH; Hung CY; Wang LJ; Liao KC; Lin CH; Tang WR; Lin YC
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):602-611. PubMed ID: 31987971
[TBL] [Abstract][Full Text] [Related]
31. Randomized phase 2 trial of S1 and oxaliplatin-based chemoradiotherapy with or without induction chemotherapy for esophageal cancer.
Yoon DH; Jang G; Kim JH; Kim YH; Kim JY; Kim HR; Jung HY; Lee GH; Song HY; Cho KJ; Ryu JS; Kim SB
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):489-96. PubMed ID: 25680595
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and feasibility of induction chemotherapy and radiotherapy plus cetuximab in head and neck cancer.
Rampino M; Bacigalupo A; Russi E; Schena M; Lastrucci L; Iotti C; Reali A; Musu A; Balcet V; Piva C; Bustreo S; Munoz F; Ragona R; Corvò R; Ricardi U
Anticancer Res; 2012 Jan; 32(1):195-9. PubMed ID: 22213307
[TBL] [Abstract][Full Text] [Related]
33. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.
Dong YY; Xiang C; Lu JX; Su YX; Pan YF; Cai R; Zhang RJ; He ZK; Liu ML; Huang H; Bai X; Tang HY; Shi YH; Wang Y; Jiang W
Strahlenther Onkol; 2016 Jun; 192(6):394-402. PubMed ID: 27215563
[TBL] [Abstract][Full Text] [Related]
34. Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer.
Lee KC; Lee SH; Lee Y; Park SH; Park J; Cho EK; Shin DB; Lee JH; Kim DY; Kim ST
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):187-91. PubMed ID: 17996392
[TBL] [Abstract][Full Text] [Related]
35. Can concurrent chemoradiotherapy replace surgery and postoperative radiation for locally advanced stage III/IV tonsillar squamous cell carcinoma?
Park G; Lee SW; Kim SY; Nam SY; Choi SH; Kim SB; Roh JL; Yoon DH; Kim SS; Park JH; Kim YS; Yoon SM; Song SY; Kim JH; Choi EK; DO Ahn S
Anticancer Res; 2013 Mar; 33(3):1237-43. PubMed ID: 23482808
[TBL] [Abstract][Full Text] [Related]
36. The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.
Zumsteg ZS; Lok BH; Ho AS; Drill E; Zhang Z; Riaz N; Shiao SL; Ma J; McBride SM; Tsai CJ; Baxi SS; Sherman EJ; Lee NY
Cancer; 2017 Apr; 123(8):1345-1353. PubMed ID: 27984656
[TBL] [Abstract][Full Text] [Related]
37. Modified weekly cisplatin-based chemotherapy is acceptable in postoperative concurrent chemoradiotherapy for locally advanced head and neck cancer.
Lu HJ; Yang CC; Wang LW; Chu PY; Tai SK; Chen MH; Yang MH; Chang PM
Biomed Res Int; 2015; 2015():307576. PubMed ID: 25793192
[TBL] [Abstract][Full Text] [Related]
38. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
Giralt J; Trigo J; Nuyts S; Ozsahin M; Skladowski K; Hatoum G; Daisne JF; Yunes Ancona AC; Cmelak A; Mesía R; Zhang A; Oliner KS; VanderWalde A
Lancet Oncol; 2015 Feb; 16(2):221-32. PubMed ID: 25596659
[TBL] [Abstract][Full Text] [Related]
39. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
[TBL] [Abstract][Full Text] [Related]
40. Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy.
Chou WC; Lai CC; Hung CY; Hsueh SW; Yeh KY; Lu CH; Tsang NM; Chang PH; Ho YW; Chen SY; Lin YC; Hung YS
Cancer Control; 2022; 29():10732748211045276. PubMed ID: 34994207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
